Molecules exhaled in the breath may help detect blood cancer , according to new research from Queen Mary University of London. The findings could enable the development of a blood cancer breathalyser, providing a rapid, low-cost way to detect disease. This tool may be particularly useful for areas with limited access to specialist equipment or expertise.

In the UK, around 40,000 people are diagnosed with blood cancer and around 16,000 people die of the disease each year. Diagnosing blood cancers can be challenging as early symptoms are often non-specific, such as fatigue and weight loss. Diagnosis usually relies on specialised tests such as imaging scans or biopsies, which can be expensive or difficult to access in some regions.

More rapid, low-cost and non-invasive test options coul

See Full Page